Skip to main content
. 2020 Jun 20;10(11):2227–2245. doi: 10.1016/j.apsb.2020.05.011

Figure 3.

Figure 3

Cytotoxicity of TPL@nano-gel against MDA-MB-231 and MCF-7 human breast cancer cells, compared with free TPL. MDA-MB-231 and MCF-7 cells were treated with various concentrations of free TPL and TPL@nano-gel (0–160 nmol/L) for 24, 48, 72 and 96 h, respectively. Cell viability was assessed by MTT assay. IC50 values of cell viability in MDA-MB-231 and MCF-7 cells with free TPL and TPL@nano-gel treatment were calculated and analyzed by software GraphPad Prism 5.0 (mean ± SD, n = 3).